Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia (vol 8, pg 29, 2014)

被引：0

|

作者：

English, Brett A.

机构：

来源：

BIOMARKERS IN MEDICINE | 2014年 / 8卷 / 02期

关键词：

D O I：

10.2217/bmm.13.56

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：309 / 310

页数：2

相关论文

共 10 条

[1] Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia
English, Brett A.
Thomas, Kelan
Johnstone, Jack
Bazih, Adam
Gertsik, Lev
Ereshefsky, Larry
[J]. BIOMARKERS IN MEDICINE, 2014, 8 (01) : 29 - 49
[2] Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?
Pepe, Margaret S.
Janes, Holly
Li, Christopher I.
Bossuyt, Patrick M.
Feng, Ziding
Hilden, Jorgen
[J]. CLINICAL CHEMISTRY, 2016, 62 (05) : 737 - 742
[3] Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications (vol 74, pg 1587, 2014)
Trujillo, Toby
Dobesh, Paul P.
[J]. DRUGS, 2014, 74 (15) : 1837 - 1837
[4] Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea (vol 29, pg 494, 2014)
Baik, Yeong Ok
Choi, Seuk Keun
Kim, Jae Woo
Yang, Jae Seung
Kim, Ick Young
Kim, Chan Wha
Hong, Jang Hee
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (08) : 1182 - 1182
[5] Differences between early-phase primary psychotic disorders with concurrent, substance use and substance-induced psychoses (vol 62, pg 137, 2005)
Caton, CLM
Drake, RE
Hasin, DS
Dominguez, B
Shrout, PE
Samet, S
Schanzer, B
[J]. ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (05) : 493 - 493
[6] Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials (vol 12, pg e784, 2016)
Mengistu, B.
Ray, D.
Lockett, P.
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (10) : 954 - 954
[7] Adolescent insanity revisited: Course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study (vol 55, pg 1174, 2014)
Rembark, B.
Bazynska, A. K.
Krempa-Kowalewska, A.
Rybakowski, F.
[J]. COMPREHENSIVE PSYCHIATRY, 2015, 58 : 222 - 222
[8] Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial (vol 14, pg 281, 2014)
Grinsztejn, B.
Hosseinipour, M. C.
Ribaudo, H. J.
[J]. LANCET INFECTIOUS DISEASES, 2014, 14 (04): : 269 - 269
[9] Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis (vol 74, pg AB244, 2016)
Tan, H.
Valdez, H.
Griffiths, C.
Mrowietz, U.
Tallman, A. M.
Wolk, R.
Gordon, K. B.
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (01) : X - X
[10] RETRACTION: A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow's Feet: A New Concept of Regenerative Filler (Retraction of vol 29, pg S201, 2014)
Pak, C. S.
Lee, J.
Lee, H.
Jeong, J.
Kim, E. H.
Jeong, J.
Choi, H.
Kim, B.
Oh, S.
Kim, I
Heo, C. Y.
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (02) : 330 - 330